Pharmazeutische Präparate

European patent · EP0315218 · Deleted

Register entry

Publication number
EP0315218
Application number
EP88119741
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Feb 22, 1985
Published
May 10, 1989
Granted
Dec 22, 1993
Deleted
Feb 21, 2005
Reason
Maximum term reached
IPC classes
A61L 15/16 (2006.01)
A61K 31/40 (2006.01)
A61K 47/00 (2006.01)
A61K 9/70 (2006.01)
Priority
CH A 1008/84 01.03.1984
CH A 1753/84 06.04.1984
Divided from
EP85810072
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 31, 2005

    Maximum term reached

    Published in +pat+ No 6 in 2005

  2. May 15, 1997

    Address changed

    Owner
    Sandoz AG, Lichtstrasse 35, 4002 Basel, LTS Lohmann Therapie-Systeme, GmbH & Co. KG, Irlicherstrasse 55, D-56513 Neuwied, Germany → LTS Lohmann Therapie-Systeme, GmbH & Co. KG, Irlicherstrasse 55, D-56513 Neuwied, Germany, Novartis AG, Schwarzwaldallee 215, 4058 Basel

    Published in PIDTJ No 9 in 1997

  3. Jan 31, 1994

    Granted

    Published in PIDTJ No 2 in 1994

Parties

Inventor

Kissel, Thomas

D-7801 Ehrenkirchen 1, DE

Schrank, Henriette

CH-4125 Riehen

Hoffmann, Hans-Rainer

D-5450 Neuwied 22, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.